Filing Details
- Accession Number:
- 0001209191-22-049210
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-08 17:34:44
- Reporting Period:
- 2022-09-06
- Accepted Time:
- 2022-09-08 17:34:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1496323 | Igm Biosciences Inc. | IGMS | Pharmaceutical Preparations (2834) | 770349194 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1787362 | Bruce Keyt | C/O Igm Biosciences, Inc. 325 E. Middlefield Road Mountain View CA 94043 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-09-06 | 5,000 | $0.93 | 44,489 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-09-06 | 5,000 | $19.06 | 39,489 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-09-07 | 10,000 | $0.93 | 49,489 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-09-07 | 10,000 | $19.04 | 39,489 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-09-08 | 10,000 | $0.93 | 49,489 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-09-08 | 7,265 | $19.57 | 42,224 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-09-08 | 2,735 | $20.34 | 39,489 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2022-09-06 | 5,000 | $0.00 | 5,000 | $0.93 |
| Common Stock | Stock Option (right to buy) | Disposition | 2022-09-07 | 10,000 | $0.00 | 10,000 | $0.93 |
| Common Stock | Stock Option (right to buy) | Disposition | 2022-09-08 | 10,000 | $0.00 | 10,000 | $0.93 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 103,756 | 2023-01-12 | No | 4 | M | Direct | |
| 93,756 | 2023-01-12 | No | 4 | M | Direct | |
| 83,756 | 2023-01-12 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,013 | Indirect | See footnote |
Footnotes
- The option exercises and sales were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
- This transaction was executed in multiple trades at prices ranging from $18.75 to $19.25. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $19.00 to $19.27. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $19.25 to $20.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $20.25 to $20.75. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- The shares are held directly by the reporting person's spouse.
- The shares subject to the option are vested and exercisable as of the date hereof.
Billionaire Hedge Funds
